Author: Angeline Leishman|| Date Published: December 30, 2021
Merck’s life science business has been awarded a three-year, $136.7 million contract to stand up a factory for a critical material needed to manufacture rapid COVID-19 point-of-care tests.
MilliporeSigma said Thursday it will use the funds to establish a lateral flow membrane production facility in Sheboygan, Wisconsin, to support domestic production and supply efforts for the government’s pandemic preparedness initiative.
The business supplies its Hi-Flow Plus nitrocellulose membrane to manufacturers of medical test kits intended to diagnose infectious diseases such as COVID-19, malaria and HIV.
GreyNoise Intelligence has launched a command-and-control detection capability designed to give federal agencies earlier visibility into compromised infrastructure. GreyNoise’s new…
Textron Aviation Defense has been awarded a five-year, $150 million contract to provide sustaining engineering and program management, or SEPM, services…
Merlin, an aerospace and defense technology company, has appointed former PsiQuantum executive Mark Brunner as chief revenue officer. What Will Mark Brunner Oversee?…
Fortreum has acquired Kovr.AI, an AI-native cybersecurity compliance platform, to combine automated compliance capabilities with independent assessment services for federal…
